11C-acetate PET/CT in bladder urothelial carcinoma: Intraindividual comparison with 11C-choline

Clinical Nuclear Medicine

Volumn 37, Issue 4, 2012, Pages

  Orevi, Marina ^a   Klein, Martine ^a   Mishani, Eyal ^b   Chisin, Roland ^a   Freedman, Nanette ^a   Gofrit, Ofer N ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

11C acetate; 11C choline; bladder; PET CT; urothelial carcinoma

Indexed keywords

ACETIC ACID C 11; CHOLINE C 11; ACETIC ACID DERIVATIVE; CARBON; CHOLINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; DRUG DISTRIBUTION; DRUG TUMOR LEVEL; FEMALE; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KIDNEY PARENCHYMA; LUNG; LYMPH NODE DISSECTION; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE; PANCREAS; PELVIS LYMPH NODE; PREOPERATIVE EVALUATION; PROSTATE; RADIOCHEMISTRY; SMALL INTESTINE; SPLEEN; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; LYMPH NODE; METABOLISM; MIDDLE AGED; SCINTISCANNING; SYNTHESIS; TRANSPORT AT THE CELLULAR LEVEL; UROTHELIUM;

ACETATES; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CHOLINE; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84858146930     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31824786e7     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Frank I, Cheville JC, Blute ML, et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer. 2003;97:2425-2431. (Pubitemid 36542481)
3. Stenzl A, Cowan NC, De Santis M, et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2009;55-815.
4. Stenzl A, Cowan NC, De Santis M, et al. Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic. Arnhem, The Netherlands: European Association of Urology; 2008.
5. Paik ML, Scolieri MJ, Brown SL, et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol. 2000;163:1693.
6. Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology. 2004;233:449.
7. Kosuda S, Kison PV, Greenough R, et al. Preliminary assessment of fluorine- 18-fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med. 1997;24:615-620. (Pubitemid 27299740)
8. Roivanen A, Forsback S, Gronroos T, et al. Blood metabolism of [methyl11C] choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27:25-32. (Pubitemid 30097256)
9. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117-122. (Pubitemid 32276075)
10. Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90:525-533. (Pubitemid 37243700)
11. Soloviev D, Fin A, Chierichetti F, et al. PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. Eur J Nucl Med Mol Imaging. 2008;35:942-949.
12. Picchio M, Treiber U, Beer AJ, et al. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med. 2006;47:938-944. (Pubitemid 46939945)
13. Gofrit ON, Mishani E, Orevi M, et al. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol. 2006;176:940-944. (Pubitemid 44142556)
14. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11 choline. J Nucl Med. 1998;39:990-995. (Pubitemid 28270113)
15. Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C choline PET/CT. J Nucl Med. 2006;47:1249-1254. (Pubitemid 47544875)
16. Kato T, Tsukamoto E, Kuge Y, et al. Accumulation of [C-11] acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Imaging. 2002;29:1492-1495. (Pubitemid 35232052)
17. Oyama N, Akino H, Kanamaru H, et al. C-11 acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186. (Pubitemid 34151040)
18. Klein M, Orevi M. Urologic malignancies. In: Delbeke D, Israel O, eds. Hybrid PET/CT and SPECT/CT Imaging. New York, NY: Springer- Science+Business Media; 2010:409-443.
19. Roeda D, Dolle F, Crouzel C. An improvement of 11C acetate synthesis- nonradioactive contaminants by irradiation-induced species emanating from the 11C carbon dioxide production target. Appl Radiat Isot. 2002;57:857-860. (Pubitemid 35284221)
20. Mishani E, Ben-David I, Rozen Y, et al. [C-11]choline-automated preparation and clinical utilization. J Labelled Comp Radiopharm. 2001;44:379.
21. Mishani E, Ben-David I, Rozen Y. Improved method for the quality assurance of [C-11]choline. Nucl Med Biol. 2002;29:359.
22. Kotzerke J, Volkmer BG, Glatting G, et al. Intraindividual comparison of [C11] acetate and [C-11]choline PET for detection of metastases of prostate cancer. Nuklearmedizin. 2003;42:25-30. (Pubitemid 36231688)
23. Shiepers C, Hoh CK, Nuyts J, et al. 1-11C-acetate kinetics of prostate cancer. J Nucl Med. 2008;49:206-221.
24. Bellin MF, Roy C. Magnetic resonance lymphogaphy. Curr Opin Urol. 2007;17:65-69.
25. Leissner J, Ghoneim MA, bol-Einen H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171:139-144. (Pubitemid 37549109)